Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carter’s, Inc. (CRI): Hound Partners Ups Stake to 7%

Jonathan Auerbach is bullish on Carter’s, Inc. (NYSE:CRI) and has boosted his fund’s stake in the company. As reported in a recent filing with the Securities and Exchange Commission, Auerbach’s fund, Hound Partners, has added 307,362 shares to its holding in mid-June. As a result, Hound Partners now holds 3.71 million Carter’s, Inc. (NYSE:CRI) shares, which account for 6.92% of the company’s common stock.

Carter's, Inc. (NYSE:CRI)

Carter’s, Inc. (NYSE:CRI) has also attracted the attention of Chase Coleman and Feroz Dewan, who run Tiger Global. According to the fund’s latest 13F filing, its stake in the company has been increased by 15% during the first quarter of this year to 6.48 million shares. Larry Robbins is also bullish on this stock, having increased his fund’s stake by 47% to 1.55 million shares, during the same period. Alan Fournier and his fund, Pennant Capital Management, have also reported an increase in their holding of Carter’s, Inc. (NYSE:CRI): up 10% during Q1 to 3.18 million shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!